OneDigital Investment Advisors LLC Buys 2,661 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

OneDigital Investment Advisors LLC boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 32.7% in the third quarter, HoldingsChannel reports. The institutional investor owned 10,805 shares of the financial services provider’s stock after buying an additional 2,661 shares during the quarter. OneDigital Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,573,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Highline Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $30,000. Bbjs Financial Advisors LLC purchased a new position in iShares Biotechnology ETF during the second quarter worth about $31,000. Ashton Thomas Securities LLC bought a new stake in iShares Biotechnology ETF in the 3rd quarter worth about $36,000. Voisard Asset Management Group Inc. purchased a new stake in iShares Biotechnology ETF in the 3rd quarter valued at about $59,000. Finally, Aptus Capital Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 36.5% during the 3rd quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after buying an additional 114 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $133.38 on Monday. The stock’s 50 day moving average price is $144.49 and its 200-day moving average price is $141.78. iShares Biotechnology ETF has a twelve month low of $116.70 and a twelve month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.